Cheryl M. Corcoran, MD

Dr. Corcoran received her MD from Harvard Medical School. She completed her internship and residency in adult psychiatry at The Cambridge Health Alliance, a research fellowship in Schizophrenia Research at Columbia University, and a master’s degree in biostatistics at the Mailman School of Public Health. She is currently associate professor of psychiatry and program leader in psychosis risk at the Icahn School of Medicine at Mount Sinai.

Dr. Corcoran has research funding to study disturbances in sensory processing, language, and social cognition across stages of schizophrenia using MRI, EEG, and automated natural language processing analysis to measure semantic coherence and syntactic complexity. She has used non-invasive brain stimulation for cognitive mapping and to identify targets and circuits for therapeutic neurostimulation. Dr. Corcoran has also studied the role of stress and drug use in onset and symptom expression in schizophrenia, as well as stigma and paths to prevention and recovery. Her current research focuses on risk states and identifying brain mechanisms that underlie language disturbance and emotion recognition deficits in this population.


Brkout 1F -- Cannabinoids in Early Psychosis